During development, 17α-estradiol is a potent estrogen and carcinogen

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 577-581

  Hajek, Richard A ^a   Robertson, Audra D ^a   Johnston, Dennis A ^a   Van Nguyen, T ^a   Tcholakian, Robert K ^a   Wagner, Laura A ^a   Conti, Claudio J ^b   Meistrich, Marvin L ^a   Contreras, Nancy ^c   Edwards, Creighton L ^a   Jones, Lovell A ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinogen; Cervicovaginal; Development; Endocrine disruptor; Estradiol; Estrogen; Mouse; Neonatal

Indexed keywords

CARCINOGEN; CELL NUCLEUS DNA; CHOLESTEROL; ESTRADIOL; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENITAL SYSTEM; HYPOSPADIAS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINA DISEASE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; METABOLISM; NEWBORN; PATHOLOGY; STEREOISOMERISM; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA; VAGINA TUMOR;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; CERVIX UTERI; DNA; ESTRADIOL; FEMALE; MICE; MICE, INBRED BALB C; STEREOISOMERISM; UTERINE CERVICAL NEOPLASMS; VAGINA; VAGINAL NEOPLASMS;

EID: 0031113351     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3577     Document Type: Conference Paper

References (33)

1. Colborn T, Clement C, eds. Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton:Princeton Scientific Publishing, 1992.
2. Fechner RE. Pathologic aspects of tumors and tumor-like lesions in women taking oral contraceptive hormones. In: Estrogen and Cancer (SG Silverberg, Major FJ, eds). New York:John Wiley & Sons, 1989;111-145.
3. Takasugi N, Bern HA. Introduction: abnormal genital tract development in mammals following early exposure to sex hormones In: Toxicity of Hormones in Perinatal Life (Mori T, Nagasawa H, eds) Boca Raton, FL:CRC Press, 1988.
4. Bern HA. Diethylstilbestrol (DES) syndrome: present status of animal and human studies. In: Hormonal Carcinogenesis (Li J, Nandi S, Li SA, eds). New York:Springer-Verlag, 1992;1-81.
5. McLachlan JA, ed. Estrogens in the Environment II. New York:Elsevier Science Publishing, 1985.
6. Hajek RA, Van NT, Johnston DA, Jones LA. In vivo induction of increased DNA ploidy of mouse cervicovaginal epithelium by neonatal estrogen treatment. Biol Reprod 49:908-917 (1993).
7. Barrett JC, Hesterberg TW, Oshimura M, Tsutsui T. Role of chemically induced mutagenic events in neoplastic transformation of Syrian hamster embryo cells. In: Mechanisms of Carcinogenesis and Assays for Carcinogens (Barrett JA, Tennant RW, eds) New York:Raven Press, 1985;123-137.
8. Hillbertz-Nilsson K, Forsberg J-G. Genotoxic effects of estrogens in epithelial cells from the neonatal mouse uterine cervix: modifications by metabolic modifiers. Teratog Carcinog Mutagen 9:97-110 (1989).
9. Wheeler WJ, Cherry LM, Downs T, Hsu TC. Mitoric inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro. Mutat Res 171:31-41 (1986).
10. Scrocchi LA, Jones LA. Alteration of proto-oncogene c-fos expression in neonatal estrogenized BALB/c female mice & murine cervicovaginal tumor LJ6195. Endocrinology 129:2251-2253 (1991).
11. Li SA, Klicka JK, Li JJ. Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res 45:181-185 (1985).
12. Liehr JG. Genotoxic effects of estrogens. Mutat Res 238:269-276 (1990).
13. McLachlan JA, ed. Estrogens in the Environment. New York:Elsevier-North Holland, 1980.
14. Bern HA. The development of the role of hormones in development - a double remembrance. Endocrinology 131:2037-2038 (1992).
15. Clarke R, Dickson RB, Lippman ME. Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol 12:1-23 (1992).
16. Li JJ, Li SA, Klicka JK. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 43:5200-5204 (1983).
17. Liehr JG. 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 23:278-281 (1983).
18. Tcholakian RK, Steinberger A. Progesterone metabolism by cultured sertoli cells. Endocrinology 103:1335-1343 (1978).
19. Forsberg J-G, Kalland T. Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res 41:721-734 (1981).
20. Bhavnani BR, Woolever CA. Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus. Steroids 56:201-210 (1991).
21. Amara JF, Itallie CV, Dannies PS. Regulation of prolactin production and cell growth by estradiol: difference in sensitivity to estradiol occurrs at the level of messenger ribonucleic acid accumulation. Endocrinology 120:264-271 (1987).
22. Densmore CL, Markaverich BM, O'Malley BW, Clark JH. Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol. Biochemistry 28:7788-7796 (1989).
23. Loose-Mitchel DS, Chiappetta C, Stancel GM. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 2:946-951 (1988).
24. Pellerin I, Vuillermoz C, Jouvenot M, Royez M, Urdener L, Marechal G, Adessi G. Superinduction of c-fos gene expression by estrogen in cultured guinea-pig endometrial cells requires priming by a cyclohexamide-dependent mechanism. Endocrinology 131:1094-1100 (1992).
25. Reddel RR, Sutherland RL. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res 47:5323-5329 (1987).
26. Bigsby RM, Aixin L, Luo K, Cunha GR. Strain differences in the ontogeny of estrogen receptors in murine uterine epithelium. Endocrinology 126:2592-2596 (1990).
27. Clark HH, Williams M, Upchurch S, Eriksson H, Helton E, Markaverich BM. Effects of estradiol-17α on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. J Steroid Biochem 16:323-328 (1982).
28. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz J-L. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131:1305-1312 (1992).
29. Juransz RL, Huseby RA, Wilcox RB. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia. Cancer Res 48:14-18 (1988).
30. Jones LA, Hajek RA. Effects of estrogenic chemicals on development. Environ Health Perspect 103(Suppl 7):63-67 (1995).
31. Ekbom A, Trichopoulos D, Adami H-O, Hsieh C-C, Lan S-J. Evidence of prenatal influences on breast cancer risk. Lancet 340:1015-1018 (1992).
32. Davis DL, Bradlow HL. Can environmental estrogens cause breast cancer? Sci Am 166-172 (1995).
33. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).